The role of taxanes in HR+ve/HER2-ve metastatic breast cancer (MBC) patients (pts) from adjuvant to metastatic setting in the clinical practice: Results from GIM13-AMBRA study.

被引：1
作者：
Mustacchi, Giorgio
Cazzaniga, Marina Elena
Romagnoli, Emanuela
Montemurro, Filippo
De laurentiis, Michele
Riccardi, Ferdinando
Turletti, Anna
Beano, Alessandra
De Angelis, Claudia
Graziano, Vincenzo
Livi, Lorenzo
Del Mastro, Lucia
Biganzoli, Laura
Garrone, Ornella
De Placido, Sabina
Marchetti, Paolo
Pronzato, Paolo
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.1055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1055
引用
收藏
页数：6
相关论文
共 50 条
[31]   Effectiveness and safety of Everolimus-Exemestane (EVE-EXE) in unselected patients (pts) with HR + /HER2-Metastatic Breast Cancer (MBC): Our experience in clinical practice [J].
Mafodda, A. ;
Giannicola, R. ;
Azzarello, D. ;
Del Medico, P. ;
Raffaele, M. ;
Giuffre, C. ;
Maisano, R. .
ANNALS OF ONCOLOGY, 2016, 27
[32]   Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): Old drugs, new opportunities Preliminary results of the VICTOR-6 study [J].
Cazzaniga, M. ;
Cagossi, K. ;
Valerio, M. R. ;
Russo, S. ;
Casadei, V. ;
Scognamiglio, G. ;
Cavanna, L. ;
Toniolo, D. ;
De Conciliis, E. ;
Melegari, E. ;
Stocchi, L. ;
Gebbia, V. ;
Vandone, A. M. ;
Cursano, M. C. ;
Pinotti, G. ;
Rossello, R. ;
Ortu, S. ;
Pellegrino, B. ;
Saracchini, S. ;
Torri, V. .
ANNALS OF ONCOLOGY, 2017, 28
[33]   T-DM1 to induce response in central nervous system (CNS) metastases from Her2+ve metastatic breast cancer (MBC). [J].
McCabe, Yamini ;
Wardley, Andrew M. ;
Armstrong, Anne Caroline ;
Howell, Sacha Jon .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[34]   Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): old drugs, new results. The multicenter VICTOR-6 study [J].
Cazzaniga, M. ;
Orlando, L. ;
Melegari, E. ;
Arcangeli, V. ;
Butera, A. ;
Pinotti, G. ;
Vallini, I. ;
Mocerino, C. ;
Giovanardi, F. ;
Cretella, E. ;
Gambaro, A. ;
Pistelli, M. ;
Donati, S. ;
Pizzuti, L. ;
Spagnuolo, A. ;
Putzu, C. ;
Leonardi, V. ;
De Angelis, C. ;
Pedroli, S. ;
Torri, V. .
ANNALS OF ONCOLOGY, 2017, 28
[35]   Validation of time to treatment change (TTC) as a surrogate end-point of progression free survival (PFS) for observational trials in metastatic breast cancer patients (MBC): The GIM-13 AMBRA study. [J].
Cazzaniga, Marina Elena ;
Pronzato, Paolo ;
Meattini, Icro ;
Biganzoli, Laura ;
Taverniti, Cristiana ;
Natoli, Clara ;
De Placido, Sabino ;
Aversa, Caterina ;
Bordin, Elio ;
Giordano, Monica ;
Bologna, Alessandra ;
Diodati, Lucrezia ;
Blasi, Livio ;
Garrone, Ornella ;
Romagnoli, Emanuela ;
Mocerino, Carmela ;
D'Alonzo, Alessia ;
Piezzo, Michela ;
Mustacchi, Giorgio .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[36]   Treatment ofpatients (pts) with HER2-metastatic breast cancer (MBC) with nab-paclitaxel (nab-P) in the clinical practice setting-Results of a US Oncology survey [J].
Patt, Debra A. ;
Richardson, Paula ;
Rembert, Debra ;
Corzo, Deyanira ;
Chen, Clara .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[37]   FLUCTUATION OF HER2/NEU PROTEIN LEVELS IN CIRCULATING TUMOR CELLS (CTCS) FROM METASTATIC BREAST CANCER (MBC) PATIENTS (PTS) [J].
Bessi, S. ;
Galardi, F. ;
Truglia, M. C. ;
Pestrin, M. ;
Chiarelli, C. ;
Cappadona, S. ;
Licitra, S. ;
Biganzoli, L. ;
Giannini, A. .
ANNALS OF ONCOLOGY, 2009, 20 :50-50
[38]   Systemic therapy and overall survival (OS) in patients (pts) with brain metastases from HER2-positive (HER2+) metastatic breast cancer (MBC). [J].
Bartsch, R. ;
Berghoff, A. ;
Pluschnig, U. ;
Bago-Horvath, Z. ;
Dubsky, P. C. ;
Rottenfusser, A. ;
Wenzel, C. ;
Rudas, M. ;
Fitzal, F. ;
Dieckmann, K. ;
Gnant, M. ;
Zielinski, C. ;
Steger, G. G. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[39]   Trop-2 mRNA expression and association with clinical outcomes with sacituzumab govitecan (SG) in patients with HR+/HER2-metastatic breast cancer (mBC): Biomarker results from the phase 3 TROPiCS-02 study. [J].
Bardia, Aditya ;
Rugo, Hope S. ;
Cortes, Javier ;
Tolaney, Sara M. ;
Schmid, Peter ;
Motwani, Monica ;
Yoon, Oh Kyu ;
Boice, Jillian ;
Zhuo, Luting ;
Marme, Frederik .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[40]   Real-world clinical outcomes in patients (pts) with HR+/HER2-metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US) [J].
Tolaney, Sara M. ;
Punie, Kevin ;
Kurian, Allison W. ;
Ntalla, Ioanna ;
Verret, Wendy ;
Sadetsky, Natalia ;
Sjekloca, Nikoleta ;
Stokes, Michael ;
Jhaveri, Komal L. .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345